NEXIS试验:重症患者床上踏车联合静脉氨基酸未能改善出院时步行距离
NEXIS为多中心2期随机对照试验,纳入115例急性呼吸衰竭机械通气患者,比较早期床上踏车(45分钟/日)联合静脉氨基酸(总蛋白2.0-2.5 g/kg/d)加常规治疗与单纯常规治疗。因招募缓慢提前终止,干预安全性可接受但未改善功能结局。
要点
- 早期床上踏车联合静脉氨基酸在急性呼吸衰竭患者中安全性可接受。
- 住院期间及6个月随访的次要功能结局亦无组间差异。
核心结论
- 急性呼吸衰竭患者中,早期床上踏车联合氨基酸补充未改善6分钟步行距离或次要结局。
研究设计与样本
- 多中心2期随机对照试验,1:1随机分配至干预组或对照组,意向性治疗分析。
- 计划样本量128例可评估患者(每组64例),实际随机115例(干预组60例,对照组55例)。
主要发现
- 干预组踏车平均时长40±7分钟/日(对照组0分钟/日),总蛋白摄入1.9±0.6 g/kg/d(对照组0.9±0.6)。
- 次要结局在两组间亦相似。
临床怎么用
- 对急性呼吸衰竭机械通气患者,该联合干预虽安全但未显示功能获益。
- 不应常规以改善出院时步行能力为目的实施早期床上踏车联合静脉氨基酸。
局限性
- 因招募缓慢提前终止,未达到计划样本量。
- 研究为2期试验,可能不足以检测较小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Patients with acute respiratory failure (ARF) in intensive care units (ICUs) often experience immobility and limited nutritional intake, with long-lasting impairments. OBJECTIVE: Evaluate whether combined in-bed cycling exercise and intravenous amino acid, initiated early in the ICU, improves physical functioning. METHODS: This multicenter phase 2 trial randomly allocated patients 1:1 to protocolized in-bed cycling (45 min/d) plus intravenous amino acid (total protein intake: 2.0-2.5 g/kg/d) plus usual care vs usual care alone. Blinded assessment of 6-minute walk distance (6MWD) at hospital discharge was the primary outcome. Secondary outcomes included functional measures at ICU and hospital discharge, along with phone surveys at the 6-month follow-up. Patients were analyzed according to intention to treat. The planned sample size was 128 evaluable patients (64 per arm). MEASUREMENTS AND MAIN RESULTS: In total, 115 patients (median age ∼55 years, 55% male, Acute Physiology and Chronic Health Evaluation II ∼24, >90% mechanically ventilated) were randomized (60 intervention; 55 control). Enrollment was stopped early due to slow recruitment, with no evidence of safety concerns. The mean duration of cycling was 40 ± 7 min/d (control: 0 min/d), with total protein intake of 1.9 ± 0.6 g/kg/d (control: 0.9 ± 0.6). The median (interquartile range) 6MWD was similar between intervention and control: 108 (15-242) and 95 (0-196) m (P = .51) (median difference, 10; 95% CI, -75 to 84). Secondary outcomes were also similar between groups. CONCLUSION: Among patients with ARF, a combined intervention of early in-bed cycling and amino acid supplementation appeared safe but did not improve 6MWD or secondary outcomes during hospitalization or 6-month follow-up. Clinicaltrials.gov (NCT03021902).
引用
- Needham DM, Files DC, Hough CL, et al. Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care. Am J Respir Crit Care Med. 2026. PMID: 42438140. doi:10.1093/ajrccm/aamag287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。